Search

Search Constraints

You searched for: Author/Creator Simes, John

Search Results

1. 204. THE TUMOUR IMMUNE MICROENVIRONMENT IN OESOPHAGEAL ADENOCARCINOMA HAS PROGNOSTIC SIGNIFICANCE. (24th September 2022)

2. 280. MULTI-OMIC FEATURES OF OESOPHAGEAL ADENOCARCINOMA PATIENTS PRE-TREATED WITH PREOPERATIVE NEOADJUVANT THERAPY. (24th September 2022)

3. A randomized phase II trial of veliparib, radiotherapy, and temozolomide in patients with unmethylated MGMT glioblastoma: the VERTU study. Issue 10 (13th May 2021)

5. ACTR-24. A RANDOMIZED PHASE II TRIAL OF VELIPARIB (V), RADIOTHERAPY (RT) AND TEMOZOLOMIDE (TMZ) IN PATIENTS (PTS) WITH UNMETHYLATED MGMT (uMGMT) GLIOBLASTOMA (GBM): THE VERTU STUDY. (11th November 2019)

6. Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials. Issue 10155 (13th October 2018)

7. Biomarkers in stable coronary heart disease, their modulation and cardiovascular risk: The LIPID biomarker study. (15th December 2015)

8. Cancer multidisciplinary team meetings in practice: Results from a multi‐institutional quantitative survey and implications for policy change. Issue 1 (26th September 2017)

9. Changes in Lipoprotein‐Associated Phospholipase A2 Activity Predict Coronary Events and Partly Account for the Treatment Effect of Pravastatin: Results From the Long‐term Intervention with Pravastatin in Ischemic Disease Study. Issue 5 (23rd October 2013)

10. Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis. Issue 5 (May 2021)